Why it is time to develop the use of cognitive event-related potentials in the treatment of psychiatric diseases
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The relapse rate for many psychiatric disorders is staggeringly high, indicating that treatment methods combining psychotherapy with neuropharmacological interventions are not entirely effective. Therefore, in psychiatry, there is a current push to develop alternatives to psychotherapy and medication-based approaches. Cognitive deficits have gained considerable importance in the field as critical features of mental illness, and it is now believed that they might represent valid therapeutic targets. Indeed, an increase in cognitive skills has been shown to have a long-lasting, positive impact on the patients' quality of life and their clinical symptoms. We hereby present four principal arguments supporting the use of event-related potentials (ERP) that are derived from electroencephalography, which allow the identification of specific neurocognitive deficiencies in patients. These arguments could assist psychiatrists in the development of individualized, targeted therapy, as well as a follow-up and rehabilitation plan specific to each patient's deficit. Furthermore, they can be used as a tool to assess the possible benefits of combination therapy, consisting of medication, psychotherapy, and "ERP-oriented cognitive rehabilitation". Using this strategy, specific cognitive interventions could be planned based on each patient's needs, for an "individualized" or "personalized" therapy, which may have the potential to reduce relapse rates for many psychiatric disorders. The implementation of such a combined approach would require intense collaboration between psychiatry departments, clinical neurophysiology laboratories, and neuropsychological rehabilitation centers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
Addiction Is a Brain Disease, and It Matters
Leshner, A. I. (1997) · Science · doi:10.1126/science.278.5335.45 · Cited by 1,615
Assessment of executive functions: Review of instruments and identification of critical issues.
CHAN, R., SHUM, D., TOULOPOULOU, T., & CHEN, E. (2008) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2007.08.010 · Cited by 1,401 · cited 1×
“…and a patient’s performance in one executive function may have little or no predictive value for how the patient will perform in another); 49 and ii) time pressure is an important feature of the clinical examination, because cognitive screening needs to identify genuine impairment in as…”
Duncan, C. C., Barry, R. J., Connolly, J. F., Fischer, C., Michie, P. T., Näätänen, R., Polich, J., Reinvang, I., & Van Petten, C. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.07.045 · Cited by 1,191 · cited 1×
“In this regard, there already exist guidelines for some ERP components (MMN and P300), which could be clinically implemented.(93) For other components, normative data remains to be gathered (P50, NoGo P300, and ERN).”
BackgroundResting-state functional connectivity in neuropsychiatric disorders
Greicius, M. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328306f2c5 · Cited by 1,180
Characterizing cognition in ADHD: beyond executive dysfunction
Castellanos, F. X., Sonuga-Barke, E. J. S., Milham, M. P., & Tannock, R. (2006) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2006.01.011 · Cited by 1,170 · cited 1×
“25 In schizophrenic patients, literature data reports a substantial decrease in cognitive function of about 1.0–1.75 standard deviations below the normal mean.”
InfluentialA meta-analysis of cognitive deficits in euthymic patients with bipolar disorder
Robinson, L. J., Thompson, J. M., Gallagher, P., Goswami, U., Young, A. H., Ferrier, I. N., & Moore, P. B. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.02.016 · Cited by 962
Green, M. F., Nuechterlein, K. H., Gold, J. M., Barch, D. M., Cohen, J., Essock, S., Fenton, W. S., Frese, F., Goldberg, T. E., Heaton, R. K., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.023 · Cited by 919
Wiers, R. W., Eberl, C., Rinck, M., Becker, E. S., & Lindenmeyer, J. (2011) · Psychological Science · doi:10.1177/0956797611400615 · Cited by 912
Chiesa, A., & Serretti, A. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.08.011 · Cited by 650
Cited by
and the Subjective Cognitive Decline Initiative (SCD-I) Working Group, Smart, C. M., Karr, J. E., Areshenkoff, C. N., Rabin, L. A., Hudon, C., Gates, N., Ali, J. I., Arenaza-Urquijo, E. M., Buckley, R. F., et al. (2017) · Neuropsychology Review · doi:10.1007/s11065-017-9342-8 · Cited by 145
Smart, C. M., Segalowitz, S. J., Mulligan, B. P., Koudys, J., & Gawryluk, J. R. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150992 · Cited by 123
Almeida-Antunes, N., Crego, A., Carbia, C., Sousa, S. S., Rodrigues, R., Sampaio, A., & López-Caneda, E. (2021) · NeuroImage: Clinical · doi:10.1016/j.nicl.2020.102537 · Cited by 46
Jiang, S., Yan, C., Qiao, Z., Yao, H., Jiang, S., Qiu, X., Yang, X., Fang, D., Yang, Y., Zhang, L., et al. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.03.032 · Cited by 37
Metadata
- Authors
- Campanella, S.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2013-11
- Volume
- 9
- Pages
- 1835
- ISSN
- 1176-6328 (ISSN-L)
- OpenAlex
- W2153635153
- Cited by
- 51
- References
- 19
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Why it is time to develop the use of cognitive event-related potentials in the treatment of psychiatric diseases. https://app.cochat.ai/papers/10.2147/ndt.s53687
- The paper
- Campanella, S. (2013). Why it is time to develop the use of cognitive event-related potentials in the treatment of psychiatric diseases. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s53687
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.